FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3018585988> ?p ?o ?g. }

• W3018585988 endingPage "173141" @default.
• W3018585988 startingPage "173141" @default.
• W3018585988 abstract "Dapagliflozin (DAPA) or canagliflozin (CANA), Na+-dependent glucose co-transporter type 2 (SGLT2) inhibitors, were used for treatment of type II diabetes mellitus. Addition of DAPA or CANA suppressed M-type K+ current (IK(M)) in pituitary tumor (GH3) and pheochromocytoma PC12 cells. The IC50 value for DAPA- or CANA-mediated inhibition of IK(M) in GH3 cells was 0.11 or 0.42 μM, respectively. The presence of DAPA (0.1 μM) shifted the steady-state activation of IK(M) to less depolarized potential without changing the gating charge of the current. During high-frequency depolarizing pulses, IK(M) magnitude was reduced by DAPA; however, DAPA-induced block of IK(M) remained effective. The amplitude of neither erg-mediated K+ current nor hyperpolarization-activated cation current in GH3 cells was modified in the presence of 1 μM DAPA. Alternatively, addition of DAPA, CANA, phlorizin or chlorotoxin effectively suppressed α-methylglucoside-(αMG-) induced current (IαMG) in GH3 cells, albeit inability of tefluthrin (activator of INa) to suppress this current. DAPA shifted the charge-voltage relation of presteady-state IαMG in a rightward and downward direction with no change in the gating charge of the IαMG. Under current-clamp recordings, subsequent additions of DAPA, but still in the continued presence of αMG, increased the firing rate of spontaneous action potentials stimulated by αMG. Our results suggested that activity of SGLT was expressed functionally in GH3 and PC12 cells. Therefore, inhibitory actions of DAPA or CANA on the amplitude and gating of IK(M) might provide a yet unidentified mechanism through which the SGLT1 or SGLT2 activity were attenuated in unclamped cells occurring in vivo." @default.
• W3018585988 created "2020-05-01" @default.
• W3018585988 creator A5005209999 @default.
• W3018585988 creator A5008931428 @default.
• W3018585988 creator A5027912422 @default.
• W3018585988 date "2020-07-01" @default.
• W3018585988 modified "2023-10-14" @default.
• W3018585988 title "Effectiveness in the inhibition of dapagliflozin and canagliflozin on M-type K+ current and α-methylglucoside-induced current in pituitary tumor (GH3) and pheochromocytoma PC12 cells" @default.
• W3018585988 cites W1488402345 @default.
• W3018585988 cites W1496951573 @default.
• W3018585988 cites W1574738033 @default.
• W3018585988 cites W1585577685 @default.
• W3018585988 cites W1684652959 @default.
• W3018585988 cites W1821508835 @default.
• W3018585988 cites W1884858564 @default.
• W3018585988 cites W1966594374 @default.
• W3018585988 cites W1974115114 @default.
• W3018585988 cites W1985205653 @default.
• W3018585988 cites W1997018189 @default.
• W3018585988 cites W2000047428 @default.
• W3018585988 cites W2008163335 @default.
• W3018585988 cites W2008613493 @default.
• W3018585988 cites W2029265861 @default.
• W3018585988 cites W2030484782 @default.
• W3018585988 cites W2036952556 @default.
• W3018585988 cites W2037005722 @default.
• W3018585988 cites W2040258678 @default.
• W3018585988 cites W2044394324 @default.
• W3018585988 cites W2050614267 @default.
• W3018585988 cites W2051296916 @default.
• W3018585988 cites W2059423367 @default.
• W3018585988 cites W2061457508 @default.
• W3018585988 cites W2069634424 @default.
• W3018585988 cites W2071254380 @default.
• W3018585988 cites W2086213189 @default.
• W3018585988 cites W2087809163 @default.
• W3018585988 cites W2106340518 @default.
• W3018585988 cites W2127457810 @default.
• W3018585988 cites W2135938782 @default.
• W3018585988 cites W2144607034 @default.
• W3018585988 cites W2168766521 @default.
• W3018585988 cites W2171786511 @default.
• W3018585988 cites W2278329651 @default.
• W3018585988 cites W2387599933 @default.
• W3018585988 cites W2438557232 @default.
• W3018585988 cites W2514824891 @default.
• W3018585988 cites W2516573111 @default.
• W3018585988 cites W2555252228 @default.
• W3018585988 cites W2558419758 @default.
• W3018585988 cites W2579652996 @default.
• W3018585988 cites W2606161634 @default.
• W3018585988 cites W2782169822 @default.
• W3018585988 cites W2787522400 @default.
• W3018585988 cites W2789960034 @default.
• W3018585988 cites W2805363895 @default.
• W3018585988 cites W2809703743 @default.
• W3018585988 cites W2888690826 @default.
• W3018585988 cites W2889283275 @default.
• W3018585988 cites W2894488524 @default.
• W3018585988 cites W2904748522 @default.
• W3018585988 cites W2912740062 @default.
• W3018585988 cites W2917930880 @default.
• W3018585988 cites W2927240235 @default.
• W3018585988 cites W2946441652 @default.
• W3018585988 cites W2036501124 @default.
• W3018585988 doi "https://doi.org/10.1016/j.ejphar.2020.173141" @default.
• W3018585988 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32353360" @default.
• W3018585988 hasPublicationYear "2020" @default.
• W3018585988 type Work @default.
• W3018585988 sameAs 3018585988 @default.
• W3018585988 citedByCount "4" @default.
• W3018585988 countsByYear W30185859882021 @default.
• W3018585988 countsByYear W30185859882022 @default.
• W3018585988 countsByYear W30185859882023 @default.
• W3018585988 crossrefType "journal-article" @default.
• W3018585988 hasAuthorship W3018585988A5005209999 @default.
• W3018585988 hasAuthorship W3018585988A5008931428 @default.
• W3018585988 hasAuthorship W3018585988A5027912422 @default.
• W3018585988 hasConcept C12554922 @default.
• W3018585988 hasConcept C126322002 @default.
• W3018585988 hasConcept C134018914 @default.
• W3018585988 hasConcept C185592680 @default.
• W3018585988 hasConcept C2777180221 @default.
• W3018585988 hasConcept C2777422806 @default.
• W3018585988 hasConcept C4141045 @default.
• W3018585988 hasConcept C555293320 @default.
• W3018585988 hasConcept C71924100 @default.
• W3018585988 hasConcept C86803240 @default.
• W3018585988 hasConcept C98274493 @default.
• W3018585988 hasConceptScore W3018585988C12554922 @default.
• W3018585988 hasConceptScore W3018585988C126322002 @default.
• W3018585988 hasConceptScore W3018585988C134018914 @default.
• W3018585988 hasConceptScore W3018585988C185592680 @default.
• W3018585988 hasConceptScore W3018585988C2777180221 @default.
• W3018585988 hasConceptScore W3018585988C2777422806 @default.
• W3018585988 hasConceptScore W3018585988C4141045 @default.
• W3018585988 hasConceptScore W3018585988C555293320 @default.
• W3018585988 hasConceptScore W3018585988C71924100 @default.

• next